i agree, essentially. i think the market is waiting for numbers now: sales, revenues,profits - i hope there are some. or we get patents and/or fda applications (valuation similar to MPDD valuation in the balance). maybe the shareprice must be higer than a dime to fulfill the 90 day condition because of the ups and downs of the shareprice - so a certain overshooting seems necessary to me: perhaps the price will have to go to 15...20 cents.